| Released | Contributor | Author | Title | Pages | Price |
|---|
| Sep 30, 2013 | New Constructs, LLC | N/A | RAD: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | Sep 30, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - RITE AID CORPORATION (RAD-N) | 12 | $25 | | Sep 29, 2013 | Pechala's Reports | Lubomir Pechala | RITE AID CORP (RAD) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | Sep 27, 2013 | Alpha Street Research | Hunter Orr | RAD - Rite Aid Corp - Rated a Hold - Company Analysis and ASR Ranking Report | 9 | $24 | | Sep 27, 2013 | S&P Capital IQ – STARS Reports | N/A | Rite Aid | 11 | $126.50 | | Sep 27, 2013 | Pechala's Reports | Frantisek Pechala | RITE AID CORP (RAD) 12-months forecast | 1 | $15 | | Sep 27, 2013 | Reuters Investment Profile | N/A | Rite Aid Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | | Sep 26, 2013 | Plunkett Research, Ltd. | Jack W Plunkett | Rite Aid Corporation (RAD) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratios and Financial Averages | 50 | $99 | | Sep 26, 2013 | Plunkett Research, Ltd. | Jack W Plunkett | Rite Aid Corporation (RAD) Profile and Financials, plus Retail Industry Trends Analysis, Operating Ratios and Financial Averages | 41 | $99 | | Sep 26, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: CVS , GNC , GRMH , RAD , WAG -- DRUG STORES | 3 | $34.50 |
|
View All Reports for RAD ... |
|
|
0.18(3.78%) Oct 1, 4:01PM EDT|After Hours
:
4.95